[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"RTI Surgical\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100551166","acellular-dermal-matrix-investigation-in-breast-reconstruction-100551166",false,"NCT06456554","Acellular Dermal Matrix Investigation in Breast Reconstruction","ADMIRE","Inclusion Criteria:\n\n* Genetic female\n* Age 22 or older at time of consent\n* Undergoing immediate breast reconstruction\n* 2 stage breast reconstruction using pre pectoral technique\n* Nipple or skin sparing mastectomy\n* Willing and capable of providing informed consent\n* Able to comply with study requirements\n\nExclusion Criteria:\n\n* Planned concurrent reconstruction with pedicled flaps or free tissue\n* Pregnant or breast feeding\n* Investigator has determined tissue is unsuitable for two-stage breast reconstruction\n* History of psychological characteristics that may be incompatible with the surgical procedure and the prosthesis\n* Any serious and\u002For unstable pre-existing medical disorder or other conditions that could interfere with the subject's safety, the informed consent process, or compliance with the study protocol, in the opinion of the investigator\n* Vulnerable subject populations\n* Currently participating in another clinical trial that would have the potential to interfere or conflict with the treatment, follow-up, or objectives of this study\n* Prior history of neoadjuvant radiotherapy to the reconstruction site or chest wall\n* Active abscess or infection in the intended reconstruction site\n* Residual gross tumor at the intended reconstruction site\n* Active use of any tobacco\u002Fnicotine products\n* Has body mass index (BMI) \\>35\n* Uncontrolled diabetes defined as HbA1c ≥7 within 3 months prior to stage 1 procedure\n* Is currently taking medications including systemic steroids",true,"FEMALE","22 Years",{"count":20,"type":21},467,"ESTIMATED","INTERVENTIONAL",[24],"NA","Prospective, multi-center, dual-arm non-randomized clinical study in females undergoing a two-stage breast reconstruction using a pre-pectoral technique.",[27],"Breast Reconstruction","RECRUITING","2026-04-29",{"date":31,"type":32},"2026-04-30","ACTUAL",{"date":34,"type":32},"2024-11-22",{"date":36,"type":21},"2027-12",{"name":38,"class":39},"RTI Surgical","INDUSTRY",13,""]